Description
PROTEINS TO BE USED FOR CANCER RESEARCH
First action · last action
2012-04-06 · 2012-04-06
Transactions
1
First transaction's obligation
$6,000
Base + all options value (sum of deltas)
$6,000
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-04-06+$6,000= $6,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-04-06 | +$6,000 | $6,000 | PROTEINS TO BE USED FOR CANCER RESEARCH |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI J6D6NR41SF54)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E23P0098 | RPO EAST (36C24E) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $76,045 | FY2023 |
| 36C24223P0943 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $27,407 | FY2023 |
| VA24115P2024 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6810 · CHEMICALS | $0 | FY2015 |
| VA603D10022 | 249-NETWORK CONTRACT OFFICE 9 · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $9,168 | FY2011 |
| VA662D10233 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $13,807 | FY2011 |
| VA662D10234 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $11,040 | FY2011 |
Other recipients under 6505 from 553-DETROIT (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F1200 | ALEXION PHARMACEUTICALS INC | 553-DETROIT | $35,840 | FY2016 |
| VA25116F1203 | ACTELION PHARMACEUTICALS US, INC. | 553-DETROIT | $4,614 | FY2016 |
| VA25116F1198 | PFIZER INC | 553-DETROIT | $11,065 | FY2016 |
| VA25116F1088 | ALEXION PHARMACEUTICALS INC | 553-DETROIT | $35,840 | FY2016 |
| VA25116F0598 | PFIZER INC | 553-DETROIT | $11,065 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25112P1002_3600_-NONE-_-NONE- · retrieved 2026-09-26.